Clinical Trial Update: Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Mucolox and clonazepam for Burning Mouth Syndrome has been withdrawn. The study was sponsored by the University of Alberta.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burning Mouth Syndrome

Drugs mentioned

• Clonazepam (Clonazepam)
• Mucolox

Snippet

Sponsor: University of Alberta | Conditions: Burning Mouth Syndrome | Phase 4 | Status: WITHDRAWN